 <h1>Tribenzor Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>amlodipine / hydrochlorothiazide / olmesartan</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about amlodipine / hydrochlorothiazide / olmesartan. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Tribenzor.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to amlodipine / hydrochlorothiazide / olmesartan: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Drugs that act directly on the renin-angiotensin system can cause fetal toxicity, including injury and even death to the developing fetus. When pregnancy is confirmed, discontinue immediately.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, amlodipine/hydrochlorothiazide/olmesartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking amlodipine/hydrochlorothiazide/olmesartan:</p><p>
<i>More common</i>
</p><ul>
<li>Bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>rapid weight gain</li>
<li>tingling of the hands or feet</li>
<li>unusual weight gain or loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bladder pain</li>
<li>bloody or cloudy urine</li>
<li>body aches or pain</li>
<li>cough</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty with breathing</li>
<li>fainting</li>
<li>frequent urge to urinate</li>
<li>headache</li>
<li>loss of voice</li>
<li>lower back or side pain</li>
<li>swelling of the joints</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Persistent non-healing sore</li>
<li>pink growth</li>
<li>reddish patch or irritated area</li>
<li>shiny bump</li>
<li>white, yellow or waxy scar-like area</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of amlodipine / hydrochlorothiazide / olmesartan may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Diarrhea</li>
<li>muscle aches or spasms</li>
<li>nausea</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to amlodipine / hydrochlorothiazide / olmesartan: oral tablet</i></p><h3>General</h3><p>The most common adverse reactions were dizziness, peripheral edema, and headache.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache, syncope</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypoesthesia, lethargy, paresthesia, postural dizziness, vertigo</p>
<p></p>
<p>Amlodipine:</p>
<p><b>Common</b> (1% to 10%): Dizziness, headache, somnolence</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypoesthesia, paresthesia, syncope, tremor, tinnitus, postural dizziness, peripheral neuropathy</p>
<p><b>Rare</b> (less than 0.1%): Hypertonia, ataxia, migraine, amnesia, parosmia, taste perversion</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Lightheadedness, vertigo, paresthesia</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Dizziness, headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Vertigo</p>
<p><b>Postmarketing reports</b>: Lethargy<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea</p>
<p><b>Uncommon</b> (0.1% to 1%): Constipation, dry mouth, dyspepsia, upper abdominal pain, vomiting</p>
<p></p>
<p>Amlodipine:</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, nausea, dyspepsia</p>
<p><b>Uncommon</b> (0.1% to 1%): Altered bowel habits, dry mouth, vomiting, constipation, dysphagia, diarrhea, flatulence, pancreatitis, gingival hyperplasia</p>
<p><b>Rare</b> (less than 0.1%): Gastritis, loose stools</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Sialadenitis, cramping, gastric irritation, diarrhea, constipation, pancreatitis</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, diarrhea, dyspepsia, gastroenteritis, nausea</p>
<p><b>Postmarketing reports</b>: Vomiting, sprue-like enteropathy<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Muscle spasms, joint swelling</p>
<p><b>Uncommon</b> (0.1% to 1%): Back pain, pain in extremity</p>
<p></p>
<p>Amlodipine:</p>
<p><b>Common</b> (1% to 10%): Muscle cramps</p>
<p><b>Uncommon</b> (0.1% to 1%): Arthralgia, back pain, myalgia, rigors, arthrosis</p>
<p><b>Rare</b> (less than 0.1%): Muscle weakness, twitching</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Muscle spasm</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Arthritis, back pain, skeletal pain, creatine phosphokinase increased</p>
<p><b>Uncommon</b> (0.1% to 1%): Myalgia, arthralgia</p>
<p><b>Postmarketing reports</b>: Rhabdomyolysis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasopharyngitis, upper respiratory tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Cough, dyspnea</p>
<p></p>
<p>Amlodipine:</p>
<p><b>Common</b> (1% to 10%): Dyspnea</p>
<p><b>Uncommon</b> (0.1% to 1%): Epistaxis</p>
<p><b>Rare</b> (less than 0.1%): Coughing, rhinitis</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Respiratory distress, pneumonitis, pulmonary edema</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Bronchitis, cough, pharyngitis, rhinitis, sinusitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, peripheral edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Asthenia</p>
<p><b>Rare</b> (less than 0.1%): Face edema</p>
<p></p>
<p>Amlodipine:</p>
<p><b>Very common</b> (10% or more): Edema (up to 10.8%)</p>
<p><b>Common</b> (1% to 10%): Fatigue, asthenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Malaise, pain, gynecomastia, chest pain</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Weakness, fever</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Chest pain, fatigue, influenza-like symptoms, pain, peripheral edema</p>
<p><b>Postmarketing reports</b>: Asthenia, malaise<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Pollakiuria, erectile dysfunction</p>
<p></p>
<p>Amlodipine:</p>
<p><b>Common</b> (1% to 10%): Male sexual dysfunction</p>
<p><b>Uncommon</b> (0.1% to 1%): Micturition frequency, micturition disorder, nocturia, female sexual dysfunction</p>
<p><b>Rare</b> (less than 0.1%): Dysuria, polyuria</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Glycosuria</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Hematuria, urinary tract infection<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Palpitations, tachycardia, hypotension, orthostatic hypotension</p>
<p></p>
<p>Amlodipine:</p>
<p><b>Common</b> (1% to 10%): Flushing, palpitation</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypotension, peripheral ischemia, tachycardia, postural hypotension, hot flushes, vasculitis, arrhythmia, bradycardia</p>
<p><b>Rare</b> (less than 0.1%): Cardiac failure, pulse irregularity, extrasystoles</p>
<p><b>Frequency not reported</b>: Arrhythmia, myocardial infarction</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Cardiac arrhythmias, vasculitis, postural hypotension</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Uncommon</b> (0.1% to 1%): Angina pectoris, tachycardia</p>
<p><b>Rare</b> (less than 0.1%): Hypotension<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Hyperkalemia, blood potassium decreased</p>
<p></p>
<p>Amlodipine:</p>
<p><b>Uncommon</b> (0.1% to 1%): Weight gain, anorexia, thirst, hyperglycemia, weight decrease</p>
<p><b>Rare</b> (less than 0.1%): Increased appetite</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Anorexia, loss of appetite, hyperglycemia, hyperuricemia, electrolyte imbalance, hyponatremia, hypokalemia, cholesterol increased, triglycerides increased</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Hypertriglyceridemia, hyperuricemia, hyperglycemia</p>
<p><b>Rare</b> (less than 0.1%): Hyperkalemia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Renal function impaired</p>
<p><b>Uncommon</b> (0.1% to 1%): Blood creatinine increased, blood uric acid increased</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Renal failure, renal dysfunction, interstitial nephritis</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Postmarketing reports</b>: Acute renal failure, blood creatinine increased<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash</p>
<p><b>Rare</b> (less than 0.1%): Urticaria</p>
<p></p>
<p>Amlodipine:</p>
<p><b>Common</b> (1% to 10%): Pruritus, rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Alopecia, pruritus, purpura, rash, sweating increased, angioedema, rash erythematous, rash maculopapular, erythema multiforme</p>
<p><b>Rare</b> (less than 0.1%): Skin discoloration, urticaria, skin dryness, dermatitis, cold and clammy skin</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Purpura, photosensitivity, urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash, cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus, erythematosus, cutaneous vasculitis, erythema multiforme, exfoliative dermatitis</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Uncommon</b> (0.1% to 1%): Rash</p>
<p><b>Postmarketing reports</b>: Angioedema, alopecia, pruritus, urticaria<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): GGT increased</p>
<p></p>
<p>Amlodipine:</p>
<p><b>Postmarketing reports</b>: Hepatic enzymes increased, hepatitis, jaundice</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Intrahepatic cholestatic jaundice</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Hepatic enzymes increased<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Libido decreased</p>
<p></p>
<p>Amlodipine:</p>
<p><b>Uncommon</b> (0.1% to 1%): Depression, insomnia, mood changes, nervousness, abnormal dreams, anxiety, depersonalization</p>
<p><b>Rare</b> (less than 0.1%): Apathy, agitation</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Restlessness, sleep disturbances, depression<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Rare</b> (less than 0.1%): Drug hypersensitivity</p>
<p></p>
<p>Amlodipine:</p>
<p><b>Uncommon</b> (0.1% to 1%): Allergic reactions</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Anaphylactic reactions</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Postmarketing reports</b>: Anaphylactic reactions<sup>[Ref]</sup></p><h3>Ocular</h3><p>Amlodipine:</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal vision, conjunctivitis, diplopia, eye pain</p>
<p><b>Rare</b> (less than 0.1%): Xerophthalmia, abnormal visual accommodation</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Transient blurred vision, xanthopsia<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Amlodipine:</p>
<p><b>Uncommon</b> (0.1% to 1%): Leukopenia, thrombocytopenia</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Aplastic anemia, neutropenia/agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia, bone marrow depression<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Tribenzor (amlodipine / hydrochlorothiazide / olmesartan)." Daiichi Pharmaceuticals, Montvale, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Tribenzor (amlodipine / hydrochlorothiazide / olmesartan)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>19 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: miscellaneous antihypertensive combinations</li>
<li>FDA Alerts (4)</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tribenzor &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to amlodipine / hydrochlorothiazide / olmesartan: oral tablet</i></p><h3>General</h3><p>The most common adverse reactions were dizziness, peripheral edema, and headache.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache, syncope</p><p><b>Uncommon</b> (0.1% to 1%): Hypoesthesia, lethargy, paresthesia, postural dizziness, vertigo</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Dizziness, headache, somnolence</p><p><b>Uncommon</b> (0.1% to 1%): Hypoesthesia, paresthesia, syncope, tremor, tinnitus, postural dizziness, peripheral neuropathy</p><p><b>Rare</b> (less than 0.1%): Hypertonia, ataxia, migraine, amnesia, parosmia, taste perversion</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Lightheadedness, vertigo, paresthesia</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Dizziness, headache</p><p><b>Uncommon</b> (0.1% to 1%): Vertigo</p><p><b>Postmarketing reports</b>: Lethargy<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea</p><p><b>Uncommon</b> (0.1% to 1%): Constipation, dry mouth, dyspepsia, upper abdominal pain, vomiting</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Abdominal pain, nausea, dyspepsia</p><p><b>Uncommon</b> (0.1% to 1%): Altered bowel habits, dry mouth, vomiting, constipation, dysphagia, diarrhea, flatulence, pancreatitis, gingival hyperplasia</p><p><b>Rare</b> (less than 0.1%): Gastritis, loose stools</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Sialadenitis, cramping, gastric irritation, diarrhea, constipation, pancreatitis</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Abdominal pain, diarrhea, dyspepsia, gastroenteritis, nausea</p><p><b>Postmarketing reports</b>: Vomiting, sprue-like enteropathy<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Muscle spasms, joint swelling</p><p><b>Uncommon</b> (0.1% to 1%): Back pain, pain in extremity</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Muscle cramps</p><p><b>Uncommon</b> (0.1% to 1%): Arthralgia, back pain, myalgia, rigors, arthrosis</p><p><b>Rare</b> (less than 0.1%): Muscle weakness, twitching</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Muscle spasm</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Arthritis, back pain, skeletal pain, creatine phosphokinase increased</p><p><b>Uncommon</b> (0.1% to 1%): Myalgia, arthralgia</p><p><b>Postmarketing reports</b>: Rhabdomyolysis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasopharyngitis, upper respiratory tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Cough, dyspnea</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Dyspnea</p><p><b>Uncommon</b> (0.1% to 1%): Epistaxis</p><p><b>Rare</b> (less than 0.1%): Coughing, rhinitis</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Respiratory distress, pneumonitis, pulmonary edema</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Bronchitis, cough, pharyngitis, rhinitis, sinusitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, peripheral edema</p><p><b>Uncommon</b> (0.1% to 1%): Asthenia</p><p><b>Rare</b> (less than 0.1%): Face edema</p><p></p><p>Amlodipine:</p><p><b>Very common</b> (10% or more): Edema (up to 10.8%)</p><p><b>Common</b> (1% to 10%): Fatigue, asthenia</p><p><b>Uncommon</b> (0.1% to 1%): Malaise, pain, gynecomastia, chest pain</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Weakness, fever</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Chest pain, fatigue, influenza-like symptoms, pain, peripheral edema</p><p><b>Postmarketing reports</b>: Asthenia, malaise<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Pollakiuria, erectile dysfunction</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Male sexual dysfunction</p><p><b>Uncommon</b> (0.1% to 1%): Micturition frequency, micturition disorder, nocturia, female sexual dysfunction</p><p><b>Rare</b> (less than 0.1%): Dysuria, polyuria</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Glycosuria</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Hematuria, urinary tract infection<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Palpitations, tachycardia, hypotension, orthostatic hypotension</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Flushing, palpitation</p><p><b>Uncommon</b> (0.1% to 1%): Hypotension, peripheral ischemia, tachycardia, postural hypotension, hot flushes, vasculitis, arrhythmia, bradycardia</p><p><b>Rare</b> (less than 0.1%): Cardiac failure, pulse irregularity, extrasystoles</p><p><b>Frequency not reported</b>: Arrhythmia, myocardial infarction</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Cardiac arrhythmias, vasculitis, postural hypotension</p><p></p><p>Olmesartan:</p><p><b>Uncommon</b> (0.1% to 1%): Angina pectoris, tachycardia</p><p><b>Rare</b> (less than 0.1%): Hypotension<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Hyperkalemia, blood potassium decreased</p><p></p><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Weight gain, anorexia, thirst, hyperglycemia, weight decrease</p><p><b>Rare</b> (less than 0.1%): Increased appetite</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Anorexia, loss of appetite, hyperglycemia, hyperuricemia, electrolyte imbalance, hyponatremia, hypokalemia, cholesterol increased, triglycerides increased</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Hypertriglyceridemia, hyperuricemia, hyperglycemia</p><p><b>Rare</b> (less than 0.1%): Hyperkalemia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Renal function impaired</p><p><b>Uncommon</b> (0.1% to 1%): Blood creatinine increased, blood uric acid increased</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Renal failure, renal dysfunction, interstitial nephritis</p><p></p><p>Olmesartan:</p><p><b>Postmarketing reports</b>: Acute renal failure, blood creatinine increased<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash</p><p><b>Rare</b> (less than 0.1%): Urticaria</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Pruritus, rash</p><p><b>Uncommon</b> (0.1% to 1%): Alopecia, pruritus, purpura, rash, sweating increased, angioedema, rash erythematous, rash maculopapular, erythema multiforme</p><p><b>Rare</b> (less than 0.1%): Skin discoloration, urticaria, skin dryness, dermatitis, cold and clammy skin</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Purpura, photosensitivity, urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash, cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus, erythematosus, cutaneous vasculitis, erythema multiforme, exfoliative dermatitis</p><p></p><p>Olmesartan:</p><p><b>Uncommon</b> (0.1% to 1%): Rash</p><p><b>Postmarketing reports</b>: Angioedema, alopecia, pruritus, urticaria<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): GGT increased</p><p></p><p>Amlodipine:</p><p><b>Postmarketing reports</b>: Hepatic enzymes increased, hepatitis, jaundice</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Intrahepatic cholestatic jaundice</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Hepatic enzymes increased<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Libido decreased</p><p></p><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Depression, insomnia, mood changes, nervousness, abnormal dreams, anxiety, depersonalization</p><p><b>Rare</b> (less than 0.1%): Apathy, agitation</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Restlessness, sleep disturbances, depression<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Rare</b> (less than 0.1%): Drug hypersensitivity</p><p></p><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Allergic reactions</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Anaphylactic reactions</p><p></p><p>Olmesartan:</p><p><b>Postmarketing reports</b>: Anaphylactic reactions<sup>[Ref]</sup></p><h3>Ocular</h3><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal vision, conjunctivitis, diplopia, eye pain</p><p><b>Rare</b> (less than 0.1%): Xerophthalmia, abnormal visual accommodation</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Transient blurred vision, xanthopsia<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Leukopenia, thrombocytopenia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Aplastic anemia, neutropenia/agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia, bone marrow depression<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Tribenzor (amlodipine / hydrochlorothiazide / olmesartan)." Daiichi Pharmaceuticals, Montvale, NJ. </p><h2>More about Tribenzor (amlodipine / hydrochlorothiazide / olmesartan)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>19 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: miscellaneous antihypertensive combinations</li>
<li>FDA Alerts (4)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tribenzor &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>